Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-02

FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tranylcypromine Sulfate from Actavis Pharma, Inc. (Tranylcypromine Sulfate).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranylcypromine sulfate (Tranylcypromine sulfate)

Snippet

SUPPL AP for TRANYLCYPROMINE SULFATE (TRANYLCYPROMINE SULFATE)